Yonggan Xue
Overview
Explore the profile of Yonggan Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chi J, Xue Y, Zhou Y, Han T, Ning B, Cheng L, et al.
ACS Nano
. 2024 Aug;
18(35):24295-24305.
PMID: 39164203
Accurately distinguishing tumor cells from normal cells is a key issue in tumor diagnosis, evaluation, and treatment. Fluorescence-based immunohistochemistry as the standard method faces the inherent challenges of the heterogeneity...
2.
Guo S, Wang E, Wang B, Xue Y, Kuang Y, Liu H
Ann Surg Oncol
. 2023 Nov;
31(3):2078-2089.
PMID: 37996637
Background: Prognostic models based on multiomics data may provide better predictive capability than those established at the single-omics level. Here we aimed to establish a prognostic model for resectable gastric...
3.
Wang H, Sun Y, Zhang Z, Yang X, Ning B, Senyushkin P, et al.
Anal Chem
. 2023 Jul;
95(31):11769-11776.
PMID: 37489945
Biomolecular markers, particularly circulating microRNAs (miRNAs) play an important role in diagnosis, monitoring, and therapeutic intervention of cancers. However, existing detection strategies remain intricate, laborious, and far from being developed...
4.
Xue Y, Li S, Guo S, Kuang Y, Ke M, Liu X, et al.
BMC Geriatr
. 2023 Feb;
23(1):105.
PMID: 36803225
Background: The incidence of colorectal cancer increases with aging. Curative-intent surgery based on a minimally invasive concept is expected to bring survival benefits to elderly patients (aged over 80 years)...
5.
Wang W, Meng Q, Cheng Y, Han Y, Xue Y, Kuang Y, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612087
Background: Immunodeficiency diseases (IDDs) are associated with an increased proportion of cancer-related morbidity. However, the relationship between IDDs and malignancy readmissions has not been well described. Understanding this relationship could...
6.
Li P, Meng Q, Xue Y, Teng Z, Chen H, Zhang J, et al.
Front Oncol
. 2022 Nov;
12:1000146.
PMID: 36439454
With the widespread of colonoscopy, colorectal cancer remains to be one of the most detrimental types of cancer. Though there were multiple studies investigating the genomic landscape of colorectal cancer,...
7.
Orben F, Lankes K, Schneeweis C, Hassan Z, Jakubowsky H, Krauss L, et al.
JCI Insight
. 2022 Apr;
7(10).
PMID: 35439169
Systemic therapies for pancreatic ductal adenocarcinoma (PDAC) remain unsatisfactory. Clinical prognosis is particularly poor for tumor subtypes with activating aberrations in the MYC pathway, creating an urgent need for novel...
8.
Wu D, Wang X, Xue Y, Sun C, Zhang M
J Integr Neurosci
. 2022 Apr;
21(2):55.
PMID: 35364643
Background: Recent studies have shown that the prognosis of low-grade glioma (LGG) patients is closely correlated with the immune infiltration and the expression of long-stranded non-coding RNAs (lncRNAs). It's meaningful...
9.
Zhao S, Xu M, Liu R, Xue Y, Nie J, Chang Y
Chemistry
. 2022 Mar;
28(24):e202200113.
PMID: 35324048
A new kind of small organic NIR-II fluorophore molecule (ZS-1010) based on intermolecular charge transfer was developed as a NIR-II fluorescent probe for trimethylamine (TMA) detection, which is important for...
10.
Xue Y, Ning B, Liu H, Jia B
BMC Gastroenterol
. 2022 Mar;
22(1):127.
PMID: 35300596
Background: Colon cancer remains one of the most common malignancies across the world. Thus far, a biomarker, which can comprehensively predict the survival outcomes, clinical characteristics, and therapeutic sensitivity, is...